IDYA — Ideaya Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $2.77bn
- $2.24bn
- $23.39m
- 37
- 13
- 92
- 44
Annual cashflow statement for Ideaya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -42 | -34.5 | -49.8 | -58.7 | -113 |
| Depreciation | |||||
| Non-Cash Items | 1.7 | 4.17 | 10.1 | 10.9 | 6.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.284 | 84.4 | -17.8 | -41.6 | -11.7 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -39.3 | 55.5 | -55.8 | -87.2 | -115 |
| Capital Expenditures | -1.35 | -0.493 | -2.64 | -3.44 | -2.37 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.62 | -146 | -67 | -30 | -156 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 2.27 | -146 | -69.7 | -33.4 | -158 |
| Financing Cash Flow Items | 0 | 20 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 50.6 | 129 | 145 | 97.2 | 363 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.6 | 38 | 20 | -23.4 | 89 |